Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
836.00    -11.00 (-1.30%)
Bid:
835.00
Ask:
845.00
Spread: 10.00 (1.198%)
Market Cap: £788.45m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

Director/PDMR Shareholding - Replacement

19 Aug 2025 11:08

RNS Number : 9183V
Polar Capital Holdings PLC
19 August 2025
 

19 August 2025

 

The following amendments have been made to the Director/PDMR Shareholding announcement released on 15 August 2025 at 9:42am under RNS No 5227V.

 

The prices have been amended.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Polar Capital Holdings plc ("Polar Capital" or the "Company")

 

Notification of Transactions by Persons Discharging Managerial Responsibilities (PDMRs)/Persons Closely Associated (PCAs)

 

The Company was notified on 13 August 2025 that Ms. Rachel Stynes purchased 1,801 ordinary shares of 2.5p each ("Ordinary Shares") following an automatic dividend reinvestment for her personal holding at an aggregated price of 486.55p per share. Following this transaction Ms. Stynes is interested in a total of 32,033 Ordinary Shares representing 0.03% of the Company's issued share capital.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Rachel Stynes

2

 

Reason for the notification

 

a)

 

Position/status

 

Head of Human Resources

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Polar Capital Holdings plc

b)

 

LEI

 

549300OXX7YE1947B825

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5p each

Identification code

GB00B1GCLT25

b)

 

Nature of the transaction

 

Acquisition following dividend reinvestment

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

487.59 pence per share

980

485.50 pence per share

821

d)

 

Aggregated information

as in 4 c) above

- Aggregated volume

1801

- Price

486.55 pence per share

 

e)

 

Date of the transaction

 

13/08/2025

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

Enquiries:

 

Polar Capital +44 (0)20 7227 2700

Gavin Rochussen (Chief Executive)

Samir Ayub (CFO)

 

Deutsche Numis - Nomad and Joint Broker +44 (0)20 7260 1000

Giles Rolls (QE)

Charles Farquhar

 

Peel Hunt LLP - Joint Broker +44 (0)20 3597 8680

Andrew Buchanan

Sam Milford

 

Camarco +44 (0)20 7757 4995

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEPNFELSEFA
Date   Source Headline
9th Apr 20207:00 amRNSAuM Update
7th Apr 20204:40 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSBoard Changes
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
12th Mar 20208:37 amRNSIssue of Equity
2nd Mar 20207:00 amRNSTotal Voting Rights
28th Feb 20204:41 pmRNSSecond Price Monitoring Extn
28th Feb 20204:36 pmRNSPrice Monitoring Extension
21st Feb 202011:51 amRNSForm 8.3 - Redde PLC
21st Feb 20209:59 amRNSIssue of Equity
20th Feb 20201:54 pmRNSForm 8.3 - Redde PLC
18th Feb 202011:14 amRNSForm 8.3 - Redde PLC
18th Feb 202010:28 amRNSChange of Auditor
17th Feb 20202:44 pmRNSForm 8.3 - Redde PLC
13th Feb 20202:37 pmRNSIssue of Equity
13th Feb 20207:00 amRNSTeam Acquisition
7th Feb 20201:09 pmRNSForm 8.3 - Redde PLC
6th Feb 20202:45 pmRNSForm 8.3 - Redde PLC
5th Feb 20202:33 pmRNSForm 8.3 - Redde PLC
3rd Feb 202011:14 amRNSBlock listing Interim Review
28th Jan 20201:06 pmRNSForm 8.3 - Redde PLC
22nd Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
21st Jan 20202:26 pmRNSForm 8.3 - Redde PLC
21st Jan 20202:12 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20202:01 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20201:37 pmRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
16th Jan 202012:28 pmRNSForm 8.3 - Redde PLC
16th Jan 202012:26 pmRNSForm 8.3 - Consort Medical PLC
15th Jan 202012:20 pmRNSForm 8.3 - Redde PLC
14th Jan 202012:00 pmRNSForm 8.3 - Redde PLC
13th Jan 20201:49 pmRNSForm 8.3 - Redde Plc
10th Jan 20201:09 pmRNSForm 8.3 - Redde Plc
9th Jan 20207:00 amRNSAuM Update
30th Dec 201912:35 pmRNSForm 8.3 - Redde PLC
24th Dec 201911:35 amRNSForm 8.3 - Redde PLC
23rd Dec 20193:24 pmRNSForm 8.3 - Redde PLC
20th Dec 201911:18 amRNSForm 8.3 - Redde PLC
19th Dec 20192:17 pmRNSForm 8.3 - Redde PLC
18th Dec 20191:42 pmRNSForm 8.3 - Consort Medical PLC
17th Dec 201910:58 amRNSForm 8.3 - Consort Medical Plc
17th Dec 20199:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.